/ /

Ben Schwartz
Ben Schwartz is Associate Editor, Dermatology Times & Urology Times.
New Products: Two-in-one wire device combines access, safety guides
Other products discussed include an updated prostate tissue ablation device, a contrast agent for voiding ultrasonography, a bladder cancer test and more.
Uro Pipeline: FDA accepts biologics license application for bladder Ca agent
Other pipeline developments discussed include an implantable device for OAB treatment, a subcutaneous hypogonadism treatment, efficacy results for an HPV drug, and the status of a device-based BPH treatment.
Study: Compound found in vegetables could have anti-aging effects
A recent study found that the compound, NMN, boosts production of NAD+ in mice and could have anti-aging effects along with additional benefits, but more research is necessary to determine its effect on humans.
New Products: Hybrid basket, grabber provides capture, release of multiple stone sizes
Other products discussed include a stent system for treating ureteral obstructions, a male infertility test, and more.
Uro Pipeline: Data from mUC combination therapy suggests efficacy, safety
Other pipeline developments discussed include a bladder cancer test, a male infertility assay, and the first oral dosage treatment for hypogonadism.
Entrepreneur bets on farm fresh eggs to soothe sensitive skin conditions
A fourth-generation soap artisan has created a company and skincare line that uses farm fresh eggs to relieve dermatologic conditions such as atopic dermatitis and eczema.
New Products: Test launched to improve prostate biopsy decision process
Other new products discussed in this article include a surgical training model, devices designed to improve prostate biopsy accuracy, an updated label and more.
Uro Pipeline: FDA committee votes in favor of nocturia treatment approval
Other pipeline developments discussed in this article include the initiation of an intravesical bladder cancer study, a gel treatment for ED that has met its primary endpoint, a patent awarded for the first rechargeable implantable SNM along with some other advancements.
Study: Wearable patch may minimize peanut allergy
Study: Wearable patch may minimize peanut allergy
A wearable skin patch (Viaskin, DBV Technologies) may help treat peanut allergy, specifically in children and young adults, according to one-year results of an ongoing trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) and conducted by the NIAID-funded Consortium of Food Allergy Research(CoFAR).
Tips for taking advantage of Labor Day 2016
Tips for taking advantage of Labor Day 2016
Dermatologists, once considered generally immune to burnout, are seeing a sharp increase in occupational fatigue and we're offering some ideas for this Labor Day Weekend to help regain that strong work-life balance.

Poll

View Results